Overactive Bladder - Results from #1800

Important drug-drug interactions for treatments that target overactive bladder syndrome - Abstract November 26, 2013

Repeated botulinum toxin type A (Dysport®) injections for women with intractable detrusor overactivity: A prospective outcome study - Abstract November 25, 2013

Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: Results from single- and multiple-dose studies - Abstract November 23, 2013

Cost-effectiveness of test phase implantation strategies for InterStim® sacral neuromodulation - Abstract November 21, 2013

Defining response and non-response to treatment in patients with overactive bladder: A systematic review - Abstract November 20, 2013

Does concomitant diabetes affect treatment responses in overactive bladder patients? - Abstract November 19, 2013

Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States - Abstract November 18, 2013

How to define a refractory idiopathic overactive bladder? - Abstract November 15, 2013

Solifenacin in women with de novo overactive bladder post TVT-O: Is it effective? - Abstract November 15, 2013

Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain - Abstract November 14, 2013

Effectiveness of retropubic tension-free vaginal tape and transobturator inside-out tape procedures in women with overactive bladder and stress urinary incontinence - Abstract November 12, 2013

Long-term adherence to antimuscarinic therapy in everyday practice: A systematic review - Abstract November 11, 2013

Patient-reported outcome of solifenacin treatment among women experiencing urinary urgency and urgency incontinence - Abstract November 8, 2013

Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: A randomized, double-blind, placebo-controlled study - Abstract November 8, 2013

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability - Abstract November 6, 2013

Comparison of motor and sensory response of InterStim® for overactive bladder syndrome - Abstract November 5, 2013

Treatment of overactive bladder syndrome with urethral calibration in women - Abstract November 4, 2013

Urologists' referral attitude for sacral neuromodulation for treating refractory idiopathic overactive bladder syndrome: Discrete choice experiment - Abstract November 1, 2013

Effect of long-term exercise on voiding functions in obese elderly women - Abstract October 31, 2013

Therapeutic benefit in patients switching tolterodine to other novel antimuscarinic agents - Abstract October 30, 2013

Page 91 of 122